Clinical Implication of Elevated Human Cervical Cancer Oncogene-1 Expression in Esophageal Squamous Cell Carcinoma

Journal of Histochemistry and Cytochemistry

Volumn 60, Issue 7, 2012, Pages 512-520

  Liu, Ying ^a,b   Li, Ke ^b   Ren, Zhonghai ^c   Li, Shenglei ^a   Zhang, Hongyan ^a   Fan, Qingxia ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c Nanyang Central Hospital   (China)

Author keywords

esophageal squamous cell carcinoma; human cervical cancer oncogene 1; molecular marker; prognosis; survival curve

Indexed keywords

HUMAN CERVICAL CANCER ONCOGENE 1; MESSENGER RNA; ONCOPROTEIN; UNCLASSIFIED DRUG; LETMD1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS DYSPLASIA; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; WESTERN BLOTTING; BIOSYNTHESIS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 84865839920     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412444437     Document Type: Article

References (28)

1. Chung YJ,Kim JW.Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer.Histol Histopathol. 2005;20:999-1003.
2. Edwards BK,Brown ML,Wingo PA,Howe HL,Ward E,Ries LA,Schrag D,Jamison PM,Jemal A,Wu XC, et al.Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.J Natl Cancer Inst. 2005;97:1407-1427.
3. Ekman S,Dreilich M,Lennartsson J,Wallner B,Brattstrom D,Sundbom M,Bergqvist M.Esophageal cancer: current and emerging therapy modalities.Expert Rev Anticancer Ther. 2008;8:1433-1448.
4. Enzinger PC,Ilson DH,Kelsen DP.Chemotherapy in esophageal cancer.Semin Oncol. 1999;26:12-20.
5. Ha SA,Lee YS,Shin SM,Kim HK,Kim S,Namkoong H,Kim HJ,Jung SM,Chung YJ,Jung SS, et al.Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status.BMC Cancer. 2009;9:51.
6. Ha SA,Shin SM,Kim HK,Kim S,Namkoong H,Lee YS,Kim HJ,Jung SM,Chung YJ,Park YG, et al.Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity.J Cell Mol Med. 2009;13:3868-3875.
7. Hofstetter W,Swisher SG,Correa AM,Hess K,Putnam JB,Ajani JA,Dolormente M,Francisco R,Komaki RR,Lara A, et al.Treatment outcomes of resected esophageal cancer.Ann Surg. 2002;236:376-384.
8. Jirun P,Zhang G,Kim HK,Ha SA,Zhongtian J,Shishi Q,Zhuqingqing C,Lei G,Yoo J,Kim S, et al.Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.Dis Markers. 2011;30:307-315.
9. Jung SS,Park HS,Lee IJ,Namkoong H,Shin SM,Cho GW,Ha SA,Park YG,Lee YS,Ko J, et al.The HCCR oncoprotein as a biomarker for human breast cancer.Clin Cancer Res. 2005;11:7700-7708.
10. Ko J,Lee YH,Hwang SY,Lee YS,Shin SM,Hwang JH,Kim J,Kim YW,Jang SW,Ryoo ZY, et al.Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.Oncogene. 2003;22:4679-4689.
11. Ko J,Shin SM,Oh YM,Lee YS,Ryoo ZY,Lee YH,Na DS,Kim JW.Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.Oncogene. 2004;23:1950-1953.
12. Li S,Jiao J,Lu Z,Zhang M.An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.Oncol Rep. 2009;21:1223-1233.
13. Li S,Xi Y,Zhang H,Wang Y,Wang X,Liu H,Chen K.A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation.Oncol Rep. 2010;24:997-1004.
14. Liu HT,Wang N,Wang X,Li SL.Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.J Surg Oncol. 2010;102:683-688.
15. Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods. 2001;25:402-408.
16. Parkin DM,Bray F,Ferlay J,Pisani P.Global cancer statistics, 2002.CA Cancer J Clin. 2005;55:74-108.
17. Roder JD,Stein HJ,Siewert JROesophageal carcinoma. Berlin, Germany: Springer-Verlag; 1995:37.
18. Shin SM,Chung YJ,Oh ST,Jeon HM,Hwang LJ,Namkoong H,Kim HK,Cho GW,Hur SY,Kim TE, et al.HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.Gastroenterology. 2006;130:2074-2086.
19. Siersema PD.Esophageal cancer.Gastroenterol Clin North Am. 2008;37:943-964.
20. Urschel JD,Vasan H,Blewett CJ.A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.Am J Surg. 2002;183:274-279.
21. Wang L,Zhang Z,Wang Y,Zhang R,Chopp M.Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats.Stroke. 2004;35:1732-1737.
22. Xia JB,Zhang ZH,Tian YJ,Meng ZJ,Yu ZQ,Zhao XP,Yang DL.Cloning, prokaryotic expression and polyclonal antibody preparation of HCCR: a new biomarker for hepatocellular carcinoma.Zhonghua Gan Zang Bing Za Zhi. 2006;14:101-104.
23. Xu Z,Zhang Y,Jiang J,Yang Y,Shi R,Hao B,Zhang Z,Huang Z,Kim JW,Zhang G.Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.BMC Cancer. 2010;10:161.
24. Yang CS.Research on esophageal cancer in China: a review.Cancer Res. 1980;40:2633-2644.
25. Yang Y,Zhang GX,Shi RH,Lin Y,Hao B,Wang XY,Wang HD,Huang ZH.Overexpression of HCCR in hepatocellular carcinoma cells and its clinical significance.Zhonghua Gan Zang Bing Za Zhi. 2007;15:223-224.
26. Yoon SK,Lim NK,Ha SA,Park YG,Choi JY,Chung KW,Sun HS,Choi MJ,Chung J,Wands JR, et al.The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.Cancer Res. 2004;64:5434-5441.
27. Zeng H,Xu L,Xiao D,Zhang H,Wu X,Zheng R,Li Q,Niu Y,Shen Z,Li E.Altered expression of ezrin in esophageal squamous cell carcinoma.J Histochem Cytochem. 2006;54:889-896.
28. Zhou L,Liu J,Luo F.Serum tumor markers for detection of hepatocellular carcinoma.World J Gastroenterol. 2006;12:1175-1181.